Pharma News for the week of August 24, 2020

 

The Centers for Disease Control and Prevention is no longer recommending testing for everyone who’s been exposed to Covid-19, saying people who don’t have symptoms “do not necessarily need a test. ”The agency quietly revised its testing guidance for asymptomatic individuals Monday, advising people who are vulnerable to the virus to get tested if they have been within 6 feet of an infected individual for at least 15 minutes. (CNBC)

Though rare, it is possible that people who have recovered from Covid-19 could be reinfected, as a recent Hong Kong study suggests, the World Health Organization said Wednesday. On Monday, researchers released a study that found what appears to be the first documented case of Covid-19 reinfection, in a 33-year-old man. The man was first infected in late March and then again roughly 4½ months later, according to STAT News“It doesn’t mean that it’s happening a lot; we know that it’s possible,” Maria Van Kerkhove, head of the WHO’s emerging diseases and zoonosis unit, said during a live Q&A session. “It is something that we knew could be possible based on our experience with other human coronaviruses.” (CNBC)

The current Administration in Washington is gambling on deregulation of the Food and Drug Administration. Regulations on Covid-19 testing meant to keep Americans safe are weakened by the Administration in a recent executive order. FDA expedited the approval of a Covid-19 treatment—convalescent plasma—against the advice of its internal experts and those at the National Institute of Health. Were the federal government to continue this theme, one could expect the approval of an underregulated Covid-19 vaccine in the coming months, regardless of definitive proof, safety, or efficacy, something both the governments of China and Russia appear to have done. (Forbes)

The research was conducted by the University of North Carolina (UNC), the Saudi Health Council and the World Bank. The team looked at data from 75 studies around the world which included 400,000 coronavirus patients. The study found that obese people with the virus were twice as likely to end up in hospital and 74% more likely to be transferred to an intensive care unit. They were also 48% more at risk of dying than non-obese people. (Pharmafile)

en_USEnglish
en_USEnglish